Latest filing published 22 Jan 2008 for ARIAD PHARMACEUTICALS INC.
No signal scores available.
This profile gathers the share dealings of Burton E. Sobel across 3 companies, led by Oruka Therapeutics, Inc., New River Pharmaceuticals Inc and Ariad Pharmaceuticals Inc. The record holds 29 filings, for trades running from 9 January 2006 to 17 January 2008.
No open-market purchase appears, only 18 sales worth €2.4M. The rest of the record consists of 11 option exercises.
On 22 January 2008 came the latest disclosure, an option exercise in Ariad Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations